Health Care for 2016

Open Enrollment: November 1st, 2015 - January 31st, 2016
Enrollment for health care plans on the insurance marketplace is now open!
Join us for one of our educational sessions to learn more, or visit for more information.

Apply Here » Insurance Tips »

Newly Diagnosed?

Were you or a family member just diagnosed with a bleeding disorder?

We can help! We can provide information on bleeding disorders, medical services, Hemophilia treatment centers and Hemotologists, medical products and treatments. We can also connect you with other families and persons with bleeding disorders.

Get in touch »

About BDAI

The Bleeding Disorders Alliance Illinois (BDAI) supports families affected by inherited bleeding disorders such as Hemophilia and von Willebrand disease by providing its members with the unbiased medical information and resources that allow them to live a healthy and active lifestyle. This neutral information is especially important for families seeking answers and support soon after the initial diagnosis.

BDAI also fosters a welcoming community for families to meet, interact and share information and advice. Through education and support, BDAI helps its members advocate on their own behalf with public and private insurance providers, medical services and government agencies, while representing the bleeding community in the world at large.

Next Event All Events »

Getting Ready for What's Next

December 03: 6:00PM - 8:00PM


Learn more about what is coming next for you and your family in regards to insurance for 2016.

Event in partnership with Biogen.


Testing for Inhibitors

If you have hemophilia, should you be tested for an inhibitor?
Yes! According to new guidelines recently released from the National Hemophilia Foundation's (NHF's) Medical and Scientific Advisory Council (MASAC), if you have hemophilia (an inherited bleeding disorder in which the blood does not clot properly) you should be tested for inhibitors at least once every year. Read below to learn more about testing and minimizing the risk for inhibitors.

Learn More Here »

New Product Available

There is a new treatment available to the bleeding disorders community. The U.S. Food and Drug Administration approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have Hemophilia A. Read more about this product below.

Full Article »

Support BDAI While Shopping!

If you use Amazon, consider supporting BDAI while you shop, its easy! Instead of logging into, simply go to instead and choose the Bleeding Disorders Alliance Illinois as the charity you wish to support. Then, when you shop Amazon will donate a portion of your purchase to support BDAI at no additional cost to you. Spread the word!

Amazon Smile »

The Value of HTCs

Hemophilia Treatment Centers are a great resource for the bleeding disorders community. Check out this NHF video on the many reasons why these treatment centers are so important!

Video »

SponsorsAll Sponsors »

BDAI Partner Council

We wish to thank our leading contributors by providing a direct link to their web sites by clicking on the logos above.

BDAI does not endorse any specific product or service, and cannot be responsible for the website content of links to sites other than the


If you are interested in advertising on BDAI's website please call 312-427-1495